{"Content: ":"KD-414 is a COVID-19 vaccine candidate developed by Japanese biotechnology company KM Biologics Co.[1][2][3] Results of a phase 1/2 clinical trial for this vaccine were released as a preprint in June 2022.[4] This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.","Title":"KD-414 - Wikipedia","KeyID":"11154","URL":"https://en.wikipedia.org/wiki/KD-414"}